Fig. 1From: Crohn’s disease and ulcerative colitis patient-reported outcomes signs and symptoms for the remote management of inflammatory bowel disease during the COVID-19 pandemicCD bowel signs and symptoms (a) and abdominal symptoms (b) measures of patients defined in clinical remission or suffering from disease relapse (active) by global clinical assessment. ROC curves of CD bowel signs and symptoms (c) and abdominal symptoms (d) referred to disease activity status by global clinical assessment. Statistical significance of differences (p value) is reported in the plot area. AUC: area under the curve. (ns) not significantBack to article page